4 research outputs found
Associations between SSRI use and RV measures in limited and adjusted models, stratified by sex for RV mass and RVEDV.
<p>*Adjusted for age, sex, race/ethnicity, height, weight, and level of education.</p>†<p>Adjusted for age, sex, race/ethnicity, height, weight, level of education, depression (Center for Epidemiologic Studies.</p><p>Depression-Scale (CES-D) ≥16), smoking (status and pack-years), hypertension, systolic and diastolic blood pressure, cholesterol, low-density lipoprotein levels, triglycerides, and statin use.</p
Associations between high affinity<sup>‡</sup> SSRI use and RV measures in limited and adjusted models, stratified by sex for RV mass and RVEDV.
<p>*Adjusted for age, sex, race/ethnicity, height, weight, and level of education.</p>†<p>Adjusted for age, sex, race/ethnicity, height, weight, level of education, depression (Center for Epidemiologic Studies Depression-Scale (CES-D) ≥16), smoking (status and pack-years), hypertension, systolic and diastolic blood pressure, cholesterol, low-density lipoprotein levels, triglycerides, and statin use.</p>‡<p>Fluoxetine, fluvoxamine, paroxetine, and sertraline.</p
Study sample.
<p>MESA: Multi-Ethnic Study of Atherosclerosis; MRI: magnetic resonance imaging; LV: left ventricle; RV: right ventricle.</p
Characteristics of the study sample and of those participants excluded.
<p>Data shown as mean ± standard deviation or %. Percentages may not add to one because of rounding.</p><p>*Citalopram.</p>†<p>Fluoxetine, fluvoxamine, paroxetine, and sertraline.</p>‡<p>Includes atypical (bupropion), monoamine oxidase inhibitors, tetracyclic (mirtazapine), and serotonin antagonist and reuptake inhibitor (trazodone and nefazodone) antidepressants.</p